Global PD-1 and PD-L1 Inhibitors Market Research Report 2020

Global PD-1 and PD-L1 Inhibitors Market Research Report 2020

Table of Contents
1 PD-1 and PD-L1 Inhibitors Market Overview
1.1 Product Overview and Scope of PD-1 and PD-L1 Inhibitors
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Humanized IgG1(Immunoglobulin 1)
1.2.3 Humanized IgG4(Immunoglobulin 5)
1.2.4 Cytokine
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 PD-1 and PD-L1 Inhibitors Sales Comparison by Application: 2020 VS 2026
1.3.2 Oral
1.3.3 Subcutaneous Injection
1.4 Global PD-1 and PD-L1 Inhibitors Market Size Estimates and Forecasts
1.4.1 Global PD-1 and PD-L1 Inhibitors Revenue 2015-2026
1.4.2 Global PD-1 and PD-L1 Inhibitors Sales 2015-2026
1.4.3 PD-1 and PD-L1 Inhibitors Market Size by Region: 2020 Versus 2026
1.5 PD-1 and PD-L1 Inhibitors Industry
1.6 PD-1 and PD-L1 Inhibitors Market Trends
2 Global PD-1 and PD-L1 Inhibitors Market Competition by Manufacturers
2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Manufacturers (2015-2020)
2.2 Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
2.3 Global PD-1 and PD-L1 Inhibitors Average Price by Manufacturers (2015-2020)
2.4 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
2.5 PD-1 and PD-L1 Inhibitors Market Competitive Situation and Trends
2.5.1 PD-1 and PD-L1 Inhibitors Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key PD-1 and PD-L1 Inhibitors Players (Opinion Leaders)
3 PD-1 and PD-L1 Inhibitors Retrospective Market Scenario by Region
3.1 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.3.1 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.2 North America PD-1 and PD-L1 Inhibitors Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.4.1 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.2 Europe PD-1 and PD-L1 Inhibitors Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific PD-1 and PD-L1 Inhibitors Market Facts & Figures by Region
3.5.1 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.2 Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.6.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.2 Latin America PD-1 and PD-L1 Inhibitors Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa PD-1 and PD-L1 Inhibitors Market Facts & Figures by Country
3.7.1 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.2 Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global PD-1 and PD-L1 Inhibitors Historic Market Analysis by Type
4.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
4.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
4.3 Global PD-1 and PD-L1 Inhibitors Price Market Share by Type (2015-2020)
4.4 Global PD-1 and PD-L1 Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global PD-1 and PD-L1 Inhibitors Historic Market Analysis by Application
5.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
5.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2015-2020)
5.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2015-2020)
6 Company Profiles and Key Figures in PD-1 and PD-L1 Inhibitors Business
6.1 Merck
6.1.1 Corporation Information
6.1.2 Merck Description, Business Overview and Total Revenue
6.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Products Offered
6.1.5 Merck Recent Development
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description, Business Overview and Total Revenue
6.2.3 Novartis PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Novartis Products Offered
6.2.5 Novartis Recent Development
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Corporation Information
6.3.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.3.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Bristol-Myers Squibb Products Offered
6.3.5 Bristol-Myers Squibb Recent Development
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.4.3 GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GlaxoSmithKline Products Offered
6.4.5 GlaxoSmithKline Recent Development
6.5 Regeneron Pharmaceuticals
6.5.1 Regeneron Pharmaceuticals Corporation Information
6.5.2 Regeneron Pharmaceuticals Description, Business Overview and Total Revenue
6.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Regeneron Pharmaceuticals Products Offered
6.5.5 Regeneron Pharmaceuticals Recent Development
6.6 Eli Lilly and Company
6.6.1 Eli Lilly and Company Corporation Information
6.6.2 Eli Lilly and Company Description, Business Overview and Total Revenue
6.6.3 Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Eli Lilly and Company Products Offered
6.6.5 Eli Lilly and Company Recent Development
6.7 Roche Genetech
6.6.1 Roche Genetech Corporation Information
6.6.2 Roche Genetech Description, Business Overview and Total Revenue
6.6.3 Roche Genetech PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Roche Genetech Products Offered
6.7.5 Roche Genetech Recent Development
6.8 AstraZeneca
6.8.1 AstraZeneca Corporation Information
6.8.2 AstraZeneca Description, Business Overview and Total Revenue
6.8.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.8.4 AstraZeneca Products Offered
6.8.5 AstraZeneca Recent Development
6.9 Jiangsu HengRui Medicine Co., Ltd.
6.9.1 Jiangsu HengRui Medicine Co., Ltd. Corporation Information
6.9.2 Jiangsu HengRui Medicine Co., Ltd. Description, Business Overview and Total Revenue
6.9.3 Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Jiangsu HengRui Medicine Co., Ltd. Products Offered
6.9.5 Jiangsu HengRui Medicine Co., Ltd. Recent Development
6.10 Curis Inc.
6.10.1 Curis Inc. Corporation Information
6.10.2 Curis Inc. Description, Business Overview and Total Revenue
6.10.3 Curis Inc. PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Curis Inc. Products Offered
6.10.5 Curis Inc. Recent Development
6.11 Aurigene
6.11.1 Aurigene Corporation Information
6.11.2 Aurigene PD-1 and PD-L1 Inhibitors Description, Business Overview and Total Revenue
6.11.3 Aurigene PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Aurigene Products Offered
6.11.5 Aurigene Recent Development
7 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
7.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
7.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 PD-1 and PD-L1 Inhibitors Distributors List
8.3 PD-1 and PD-L1 Inhibitors Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.1.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Type (2021-2026)
10.2 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.2.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Application (2021-2026)
10.3 PD-1 and PD-L1 Inhibitors Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.3.2 Global Forecasted Revenue of PD-1 and PD-L1 Inhibitors by Region (2021-2026)
10.4 North America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.5 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.6 Asia Pacific PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.7 Latin America PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
10.8 Middle East and Africa PD-1 and PD-L1 Inhibitors Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Growth Rate Comparison by Type (2015-2026)
Table 2. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Comparison by Application: 2020 VS 2026
Table 3. Global PD-1 and PD-L1 Inhibitors Market Size by Type (Tons) (US$ Million) (2020 VS 2026)
Table 4. Global Key PD-1 and PD-L1 Inhibitors Manufacturers Covered in This Study
Table 5. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Manufacturers (2015-2020)
Table 6. Global PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers (2015-2020)
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market PD-1 and PD-L1 Inhibitors Average Price (US$/Kg) of Key Manufacturers (2015-2020)
Table 10. Manufacturers PD-1 and PD-L1 Inhibitors Sales Sites and Area Served
Table 11. Manufacturers PD-1 and PD-L1 Inhibitors Product Types
Table 12. Global PD-1 and PD-L1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key PD-1 and PD-L1 Inhibitors Players
Table 16. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Region (2015-2020)
Table 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 18. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Region (2015-2020)
Table 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 20. North America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (Tons)
Table 21. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 22. North America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 23. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 24. Europe PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (Tons)
Table 25. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 26. Europe PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific PD-1 and PD-L1 Inhibitors Sales by Region (2015-2020) (Tons)
Table 29. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Table 32. Latin America PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (Tons)
Table 33. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 34. Latin America PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales by Country (2015-2020) (Tons)
Table 37. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country (2015-2020)
Table 40. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Type (2015-2020)
Table 41. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2015-2020)
Table 42. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) by Type (2015-2020)
Table 43. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2015-2020)
Table 44. Global PD-1 and PD-L1 Inhibitors Price (US$/Kg) by Type (2015-2020)
Table 45. Global PD-1 and PD-L1 Inhibitors Sales (Tons) by Application (2015-2020)
Table 46. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 47. Global PD-1 and PD-L1 Inhibitors Sales Growth Rate by Application (2015-2020)
Table 48. Merck PD-1 and PD-L1 Inhibitors Corporation Information
Table 49. Merck Description and Business Overview
Table 50. Merck PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 51. Merck Main Product
Table 52. Merck Recent Development
Table 53. Novartis PD-1 and PD-L1 Inhibitors Corporation Information
Table 54. Novartis Corporation Information
Table 55. Novartis PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 56. Novartis Main Product
Table 57. Novartis Recent Development
Table 58. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Corporation Information
Table 59. Bristol-Myers Squibb Corporation Information
Table 60. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 61. Bristol-Myers Squibb Main Product
Table 62. Bristol-Myers Squibb Recent Development
Table 63. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Corporation Information
Table 64. GlaxoSmithKline Corporation Information
Table 65. GlaxoSmithKline PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 66. GlaxoSmithKline Main Product
Table 67. GlaxoSmithKline Recent Development
Table 68. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Corporation Information
Table 69. Regeneron Pharmaceuticals Corporation Information
Table 70. Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 71. Regeneron Pharmaceuticals Main Product
Table 72. Regeneron Pharmaceuticals Recent Development
Table 73. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Corporation Information
Table 74. Eli Lilly and Company Corporation Information
Table 75. Eli Lilly and Company PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 76. Eli Lilly and Company Main Product
Table 77. Eli Lilly and Company Recent Development
Table 78. Roche Genetech PD-1 and PD-L1 Inhibitors Corporation Information
Table 79. Roche Genetech Corporation Information
Table 80. Roche Genetech PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 81. Roche Genetech Main Product
Table 82. Roche Genetech Recent Development
Table 83. AstraZeneca PD-1 and PD-L1 Inhibitors Corporation Information
Table 84. AstraZeneca Corporation Information
Table 85. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 86. AstraZeneca Main Product
Table 87. AstraZeneca Recent Development
Table 88. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Corporation Information
Table 89. Jiangsu HengRui Medicine Co., Ltd. Corporation Information
Table 90. Jiangsu HengRui Medicine Co., Ltd. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 91. Jiangsu HengRui Medicine Co., Ltd. Main Product
Table 92. Jiangsu HengRui Medicine Co., Ltd. Recent Development
Table 93. Curis Inc. PD-1 and PD-L1 Inhibitors Corporation Information
Table 94. Curis Inc. Corporation Information
Table 95. Curis Inc. PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 96. Curis Inc. Main Product
Table 97. Curis Inc. Recent Development
Table 98. Aurigene PD-1 and PD-L1 Inhibitors Corporation Information
Table 99. Aurigene Corporation Information
Table 100. Aurigene PD-1 and PD-L1 Inhibitors Sales (Tons), Revenue (Million US$), Price (US$/Kg) and Gross Margin (2015-2020)
Table 101. Aurigene Main Product
Table 102. Aurigene Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. PD-1 and PD-L1 Inhibitors Distributors List
Table 106. PD-1 and PD-L1 Inhibitors Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Forecast by Type (2021-2026)
Table 111. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Type (2021-2026)
Table 112. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Forecast by Application (2021-2026)
Table 115. Global PD-1 and PD-L1 Inhibitors Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global PD-1 and PD-L1 Inhibitors Sales (Tons) Forecast by Region (2021-2026)
Table 117. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 118. Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global PD-1 and PD-L1 Inhibitors Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of PD-1 and PD-L1 Inhibitors
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type: 2020 VS 2026
Figure 3. Humanized IgG1(Immunoglobulin 1) Product Picture
Figure 4. Humanized IgG4(Immunoglobulin 5) Product Picture
Figure 5. Cytokine Product Picture
Figure 6. Global PD-1 and PD-L1 Inhibitors Consumption Market Share by Application: 2020 VS 2026
Figure 7. Oral
Figure 8. Subcutaneous Injection
Figure 9. Global PD-1 and PD-L1 Inhibitors Market Size 2015-2026 (US$ Million)
Figure 10. Global PD-1 and PD-L1 Inhibitors Sales Capacity (Tons) (2015-2026)
Figure 11. Global PD-1 and PD-L1 Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 12. PD-1 and PD-L1 Inhibitors Sales Share by Manufacturers in 2020
Figure 13. Global PD-1 and PD-L1 Inhibitors Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by PD-1 and PD-L1 Inhibitors Revenue in 2019
Figure 15. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Figure 17. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 18. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
Figure 19. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 20. North America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 21. North America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 22. U.S. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 23. U.S. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 25. Canada PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 27. Europe PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 28. Germany PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 29. Germany PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 31. France PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 33. U.K. PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 35. Italy PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 37. Russia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific PD-1 and PD-L1 Inhibitors Sales Market Share by Region in 2019
Figure 39. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue Market Share by Region in 2019
Figure 40. China PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 41. China PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 43. Japan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 45. South Korea PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 47. India PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 49. Australia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 51. Taiwan PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 53. Indonesia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 55. Thailand PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 57. Malaysia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 59. Philippines PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 61. Vietnam PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 63. Latin America PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 64. Mexico PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 65. Mexico PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 67. Brazil PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 69. Argentina PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales Market Share by Country in 2019
Figure 71. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue Market Share by Country in 2019
Figure 72. Turkey PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 73. Turkey PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 75. Saudi Arabia PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2020) (Tons)
Figure 77. U.A.E PD-1 and PD-L1 Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 79. Sales Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 80. Revenue Share of PD-1 and PD-L1 Inhibitors by Type (2015-2020)
Figure 81. Revenue Market Share of PD-1 and PD-L1 Inhibitors by Type in 2019
Figure 82. Global PD-1 and PD-L1 Inhibitors Sales Growth by Type (2015-2020) (Tons)
Figure 83. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Figure 84. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application (2015-2020)
Figure 86. Global Revenue Share of PD-1 and PD-L1 Inhibitors by Application in 2020
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Regeneron Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Roche Genetech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Jiangsu HengRui Medicine Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Curis Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Aurigene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure 100. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 101. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America PD-1 and PD-L1 Inhibitors Sales (Tons) and Growth Rate Forecast (2021-2026)
Figure 106. North America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe PD-1 and PD-L1 Inhibitors Sales (Tons) and Growth Rate Forecast (2021-2026)
Figure 108. Europe PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America PD-1 and PD-L1 Inhibitors Sales (Tons) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa PD-1 and PD-L1 Inhibitors Sales (Tons) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific PD-1 and PD-L1 Inhibitors Sales (Tons) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific PD-1 and PD-L1 Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs